SAVA Research – An eminent player in the Indian pharmaceutical industry
India will witness a huge growth in its GDP in the recent years. Due to expertise talent and cost effective pharma solutions present in this nation, the pharma as well as CRAM companies in India will be worth US$20 billion manufacturing industry by 2015.
In about a decade, the Indian pharmaceutical segment will be in the top 10 pharma industry worldwide. It is expected that the sales of the pharma market in India will go up to US$43 billion in the coming decade, contributed largely by the sales of patent drugs.
India’s medical infrastructure and health services are enhancing thus paving the path for the progression of the pharma industry.
Contract research and contract manufacturing form an integral part of the Indian pharma industry and is emerging steadily in the global arena. Being in obedience to the global standard quality and low cost of resources, CRAM companies in India are attracting foreign investors and this will go up steadily in the coming years.
In this booming pharma economy, SAVA Research has emerged as a prominent player among the pharmaceutical contract manufacturers in India. SAVA’s manufacturing facilities are certified by USDA-organic, WHO-GMP and others. With an uncompromised focus on quality and efficacy SAVA caters more than 500 products.
A talent pool that comprises of more than 400 people this leading pharmaceutical contract manufacturer in India in involved in the contract research and development to suit the global market need. All the functionality of this pharma company works with one aim that is to provide “beyond the maxim care”.
Facing the ever increasing unexpected critical challenges, SAVA never compromises in making customers happy in terms of doing justice to time and providing the best quality products and services.
indianresearchcompanies 